Navigation Links
Onconova announces FDA agreement of a SPA for a pivotal phase 3 trial of Estybon in MDS
Date:10/4/2010

innovative therapy for cancer patients," said Michael Hoffman, Chairman, Board of Directors of Onconova. "We are optimistic that the strikingly positive results from ongoing trials, combined with the anticipated data from this registration trial, will help establish the utility of Estybon in this patient population, presently facing limited treatment options. We are also pursuing solid tumor indications for Estybon which is broadly active in a variety of tumor types."

Dr. Francois Wilhelm, Chief Medical Officer of Onconova added, "The Phase 1 and 2 Estybon data which were presented at the Best of ASH session of the 2009 ASH conference, demonstrated promising activity and outcomes for MDS patients treated with Estybon and provided heightened awareness of the potential therapeutic role of a Cyclin D targeted therapy for these patients."

"The Leukemia & Lymphoma Society (LLS) is committed to the rapid advancement of therapies that have strong potential for the treatment of patients with MDS" said Louis J. DeGennaro, LLS Chief Mission Officer. "LLS continues its support for the development of Estybon through our collaboration with Onconova announced in June 2010. We see this SPA as a significant step toward making this drug available to patients. "


'/>"/>

Contact: Kathryn Morris
kathryn@proncall.com
845-635-9828
PR on Call
Source:Eurekalert

Page: 1 2

Related biology news :

1. NIAID announces 25 new awards to develop radiation countermeasures
2. Aware Announces Q3 2008 Earnings Conference Call
3. Governor Doyle announces historic genomic research collaboration
4. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
5. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
6. Parkinsons Disease Foundation announces award of $150,000
7. Jefferson Department of Surgery announces new pancreas tumor registry
8. NAS announces initiative to connect entertainment industry with top experts
9. Elsevier announces winners of 3rd Annual Scopus Young Indian Scientist Award
10. VUANCE Announces Crime Scene Security and Evidentiary Tracking Development Project
11. WCC Announces Version 6 of its ELISE Smart Search and Match Platform for Employment and Biometric Matching
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014 NXT-ID, Inc., (NXTD: OTCQB) a biometric authentication company ... smart wallet, Wocket™, was recently the topic of  an interview ... Gino Pereira , CEO of NXT-ID, on July ... Mr. Gino Pereira explains how the ... cards and walks host Anita Finley through ...
(Date:7/23/2014)... Children who have been abused or neglected early ... emotional and physical health problems. In a new ... way genes are activated, which has implications for ... a particular child,s individual characteristics and genetics interacted ... understand how health problems emerge. In the new ...
(Date:7/23/2014)... North Carolina State University shows that urban "heat islands" ... States. One factor is that researchers have found warmer ... gloomy scale insect a significant tree pest ... times more adult gloomy scales on urban trees. , ... the gloomy scale in cities, and now we know ...
Breaking Biology News(10 mins):Boomer Times Gets to Know NXT-ID's Next Generation Wocket Smart Wallet; Practical, Secure and Easy to Use 2Boomer Times Gets to Know NXT-ID's Next Generation Wocket Smart Wallet; Practical, Secure and Easy to Use 3Boomer Times Gets to Know NXT-ID's Next Generation Wocket Smart Wallet; Practical, Secure and Easy to Use 4Stress tied to change in children's gene expression related to emotion regulation, physical health 2Stress tied to change in children's gene expression related to emotion regulation, physical health 3Urban heat boosts some pest populations 200-fold, killing red maples 2Urban heat boosts some pest populations 200-fold, killing red maples 3
... A detailed analysis of chromosomes 2 and 4 has ... genome and uncovered more evidence that human chromosome 2 ... researchers supported by the National Human Genome Research Institute ... reported today. , In a study published in the ...
... Patients with type 1 diabetes who received islet transplantation ... year later, according to a study in the February ... applications of biotechnology. , Type 1 diabetes remains a ... The success rate of islet (cells that produce insulin ...
... Greater Los Angeles Healthcare System conducted the largest and ... modern drugs for treating hepatitis B -- a disease ... 17 Annals of Internal Medicine, the study may help ... a degree of uncertainly exists on how to best ...
Cached Biology News:Scientists analyze chromosomes 2 and 4 2Scientists analyze chromosomes 2 and 4 3Single-donor Islet Transplantation Procedure Shows Promise For Patients With Type 1 Diabetes 2UCLA study assesses cost-effectiveness of Hepatitis B drugs 2UCLA study assesses cost-effectiveness of Hepatitis B drugs 3
(Date:7/23/2014)... and Russian Quantum Center at Skolkovo) and Mario ... the Institute of Physics in Bratislava, Slovakia) have ... particles passing through an amplifier and, conversely, when ... provided in an article published in the journal ... Quantum entangled particles are considered to be the ...
(Date:7/23/2014)... , July 23, 2014  AuraSense Therapeutics, ... as gene regulatory and immunotherapeutic agents, announced ... joined AuraSense Therapeutics, executive leadership team as ... Prior to joining AuraSense Therapeutics, Mr. ... Financial Officer of Cellular Dynamics International Inc., ...
(Date:7/23/2014)...  Having the right people at the table for ... growth and achieving clinical and operational goals. The 22 ... July 20-22, 2014, in San Diego ... healthcare experts discussing how partnerships have positively impacted their ... Chief Executive Officer of Cape Regional Medical Center located ...
(Date:7/23/2014)... , July 23, 2014 ... company of Trendlines Agtech , announced it ... Israel,s leading agricultural thermoplastics applications ... Valentis,s technology combines nanocrystalline cellulose (NCC), a ... with additional nanoparticles to produce highly improved polymeric ...
Breaking Biology Technology:Scientists find way to maintain quantum entanglement in amplified signals 2Scientists find way to maintain quantum entanglement in amplified signals 3Scientists find way to maintain quantum entanglement in amplified signals 4AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder as Chief Financial Officer 2MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2
... Merge Technologies Incorporated , d.b.a. Merge eFilm, (Nasdaq: MRGE), ... 31, 2003. Net sales for the quarter ended March 31, ... sales of $4.5 Million in the quarter ended March 31, ... was $1,3 Million generating $0.11 diluted EPS compared to $704,000 ...
... needed a way for monitoring and three-dimensional mapping ... of cardiology systems for GE Medical Systems Information ... ability to diagnose cardiac disease and enhance patient ... studies have had to work with physically separate ...
... Medical Center (WMC), Valhalla, New York, has selected Verisis developed ... Analogic Corporation , for its new Cardiology Image and ... at WMC's George E. Reed Heart Center , one ... on the east coast. The system will also extend into ...
Cached Biology Technology:Merge has 87% Increase in Net Income 2Merge has 87% Increase in Net Income 3Merge has 87% Increase in Net Income 4NY Medical Center Selects Camtronics for Cardiovascular Image and Information Management 2
Drugs and NO-drug Rat Anti-conjugated Acetyl Salicylic Acid Polyclonal Antibody...
Applications: Beadlyte® assay Stability: 2 years at 4°C (lyophilized) or 6 months at -20°C (rehydrated) ...
... Product Mouse monoclonal [SPM278] ... Small cell lung carcinoma N592 live ... Cross-reacts with Human. Not yet tested in ... one of the major glycoproteins of basement ...
Hybridization Buffer 3.6 ml...
Biology Products: